Dr. Soliman Abdel Kader Fakeeh Hospital Co. at 34.10, -0.76% today, -4.82% over five days, -0.12% year-to-date. Volume subdued at 35.6x average. The session recorded 282 trades at 35.6x normal volume. Price is trading 0.03% above intraday VWAP at 34.09.
Flow is neutral: mild buy-side pressure, smart money neutral. Order flow is balanced with no clear directional bias from either order book or smart money indicators. Risk profile is elevated: market-beta (0.90) with elevated volatility. Risk texture shows max drawdown at 16.8% with Sharpe ratio at -0.57.
Stochastic is oversold at 2.2 while RSI remains neutral-low at 43.0. Trend strength is strong in the sideways direction. Price is testing support at 34.07; resistance at 34.91 (2.4% above). Support sits 0.1% below current price while resistance is 2.4% above. Within the 52-week range (27.2–47.15), price is 27.7% below the high.
The information environment is quiet with no tracked headlines. News mix is neutral: 0 positive vs 0 negative items over 7 days from 0 total tracked. Scale anchor: market cap is 7.6B SAR in the HEALTH_CARE_EQUIPMENT_AND_SVC sector.
Positioning reflects rank 8 of 8 in HEALTH_CARE_EQUIPMENT_AND_SVC, trailing TASI by 4.58% YTD. Against a sector average daily return of -0.93%, the stock's daily return measured -0.93%, an outperformance of 0.00 percentage points. Watch whether support at 34.07 holds.
Flow:NEUTRAL
Levels:AT SUPPORT
Risk:ELEVATED
Watch whether support at 34.07 holds.
Informational only. Not financial advice.
Dr. Soliman Abdel Kader Fakeeh Hospital Co. (4017) Price Chart
485 trading days
Since Jun 2024
Dr. Soliman Abdel Kader Fakeeh Hospital Co. (4017) Technical Analysis
SIDEWAYS
RSI (14)
43
Neutral
Volatility (20D)
32.09%
Support
34.07
Resistance
34.91
Moving Averages
SMA 20
35.72
SMA 50
33.77
SMA 200
36.71
MA: Mixed bearish
RSI: Neutral
About Dr. Soliman Abdel Kader Fakeeh Hospital Co.
Dr. Soliman Abdul Kader Fakeeh Company is a prominent player in the healthcare industry of Saudi Arabia. The company specializes in hospital operation services and is renowned for providing comprehensive medical and healthcare facilities, including outpatient centers, clinical laboratories, and pharmaceutical services. Dr. Soliman Abdul Kader Fakeeh Company plays a crucial role in enhancing healthcare accessibility and quality in the region, thus addressing a fundamental societal need. The company is well-regarded for its emphasis on employing cutting-edge medical technologies and hiring highly skilled healthcare professionals to deliver premium services. This company enhances the health and well-being of its clientele by offering specialized medical treatments and preventive care, which are becoming increasingly important in the burgeoning Middle East healthcare sector. With its strategic vision and commitment to excellence, Dr. Soliman Abdul Kader Fakeeh Company holds significant market importance as it contributes to the ongoing development and transformation of regional healthcare services. As a part of the emerging healthcare landscape, it stands out for its innovative approach and dedication to patient-centered care.